Merck (MRK) Inventory (2009 - 2026)

Merck has disclosed Inventory across 18 years of filings, most recently posting $6.5 billion for Q1 2026.

• In Q1 2026, Inventory rose 4.57% year-over-year to $6.5 billion; the TTM figure through Mar 2026 stood at $6.5 billion (up 4.57% YoY), while the FY2025 annual figure was $6.7 billion, up 8.99% from the prior year.
• Inventory retreated to $6.5 billion in Q1 2026, from $6.7 billion in the prior quarter.
• Over the last five years, Inventory for MRK reached as high as $6.7 billion in Q4 2025 and fell as low as $5.5 billion in Q2 2022.
• The 5-year median for Inventory is $6.2 billion (2025), against an average of $6.2 billion.
• Annual changes were most pronounced in 2022 — Inventory slipped 9.81% — and 2024, when it grew 11.04%.
• A 5-year view of Inventory shows it stood at $5.9 billion in 2022, then advanced by 7.56% to $6.4 billion in 2023, then fell by 3.92% to $6.1 billion in 2024, then grew by 8.99% to $6.7 billion in 2025, then decreased by 2.69% to $6.5 billion in 2026.
• According to Business Quant data, Inventory over the past three periods registered $6.5 billion, $6.7 billion, and $6.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.